Tema ETFs LLC Grows Stake in Enliven Therapeutics, Inc. $ELVNMarket Beat·2 days ago, 04:24 AMELVN+1.31%
US Micro-Caps Pivot to Restructuring and Capital Preservation in 2026Global Report·Aug 8 at 04:21 AMELVN+1.31%TGHL-7.14%
The Capital Restructuring Wave: Major Shifts Across Diverse SectorsGlobal Report·Aug 7 at 04:18 AMPRU+0.30%GCT-2.55%
Enliven Therapeutics director Mika K. Derynck sells USD 9.56 million in common sharesPUBT·Aug 6 at 07:18 PMELVN+1.31%
Strategic Shifts Heat Up: Inside Intapp's AI Rollout and Photronics' Lingering CrisisGlobal Report·Aug 5 at 04:13 AMINTA-2.22%POLA-1.11%
Enliven Therapeutics (NASDAQ:ELVN) Hits New 52-Week High - What's Next?Market Beat·Aug 3 at 01:20 PMELVN+1.31%
5 Biotech Stocks That Delivered Big Gains - Key Catalysts Ahead For QURE, CDNA, ADPT, ELVN & AMLXrttnews·Aug 2 at 06:00 AMAMLX-3.78%ELVN+1.31%
Enliven Therapeutics, Inc. $ELVN is Seven Fleet Capital Management LP's 3rd Largest PositionMarket Beat·Aug 2 at 05:32 AMELVN+1.31%
Enliven Therapeutics, Inc. $ELVN is Avidity Partners Management LP's 6th Largest PositionMarket Beat·Aug 1 at 02:40 AMELVN+1.31%
Enliven Therapeutics (NASDAQ:ELVN) CFO Sells 6,018 Shares of StockMarket Beat·Jul 28 at 11:08 AMELVN+1.31%STT+1.00%
Enliven Therapeutics CMO Helen Louise Collins disposes of USD 262,213 in common sharesPUBT·Jul 21 at 04:23 PMELVN+1.31%
The Goldman Sachs Group Issues Positive Forecast for Enliven Therapeutics (NASDAQ:ELVN) Stock PriceMarket Beat·Jul 21 at 07:48 AMELVN+1.31%IVZ+1.26%
